Variant report

Variant	nsv598680
Chromosome Location	chr5:75839165-75914729
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1429)
CpG islands
(count:244)
Chromatin interactive
region (count:43)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1429 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:75879372-75879648	HepG2	liver:	n/a	n/a
2	ARID3A	chr5:75879112-75879647	K562	blood:	n/a	n/a
3	ARID3A	chr5:75842649-75843062	HepG2	liver:	n/a	n/a
4	ARID3A	chr5:75878262-75878267	K562	blood:	n/a	n/a
5	ARID3A	chr5:75840176-75840537	K562	blood:	n/a	n/a
6	ARID3A	chr5:75840098-75840519	HepG2	liver:	n/a	n/a
7	ARID3A	chr5:75894704-75894734	HepG2	liver:	n/a	n/a
8	ATF1	chr5:75840185-75840485	K562	blood:	n/a	n/a
9	ATF1	chr5:75852689-75853049	K562	blood:	n/a	n/a
10	ATF1	chr5:75904695-75905158	K562	blood:	n/a	n/a
11	ATF1	chr5:75838766-75839534	K562	blood:	n/a	n/a
12	ATF2	chr5:75852537-75853136	GM12878	blood:	n/a	n/a
13	ATF2	chr5:75904511-75905102	GM12878	blood:	n/a	n/a
14	ATF2	chr5:75904575-75905156	GM12878	blood:	n/a	n/a
15	ATF2	chr5:75838932-75839432	GM12878	blood:	n/a	n/a
16	ATF2	chr5:75840097-75840472	H1-hESC	embryonic stem cell:	n/a	n/a
17	ATF2	chr5:75843116-75843713	GM12878	blood:	n/a	n/a
18	ATF2	chr5:75885854-75886295	GM12878	blood:	n/a	n/a
19	ATF2	chr5:75885636-75886289	GM12878	blood:	n/a	n/a
20	ATF2	chr5:75842225-75843735	GM12878	blood:	n/a	n/a
21	ATF2	chr5:75877922-75878580	GM12878	blood:	n/a	n/a
22	ATF2	chr5:75877962-75878487	GM12878	blood:	n/a	n/a
23	ATF2	chr5:75852601-75853040	GM12878	blood:	n/a	n/a
24	BATF	chr5:75885837-75886185	GM12878	blood:	n/a	chr5:75886008-75886019 chr5:75886009-75886019
25	BATF	chr5:75878120-75878359	GM12878	blood:	n/a	n/a
26	BATF	chr5:75843287-75843575	GM12878	blood:	n/a	n/a
27	BATF	chr5:75885818-75886149	GM12878	blood:	n/a	chr5:75886008-75886019 chr5:75886009-75886019
28	BATF	chr5:75878063-75878435	GM12878	blood:	n/a	n/a
29	BATF	chr5:75843274-75843642	GM12878	blood:	n/a	n/a
30	BCL11A	chr5:75878060-75878454	GM12878	blood:	n/a	n/a
31	BCL11A	chr5:75878053-75878407	GM12878	blood:	n/a	n/a
32	BCL3	chr5:75878087-75878399	GM12878	blood:	n/a	n/a
33	BCLAF1	chr5:75842536-75843685	GM12878	blood:	n/a	chr5:75843310-75843319
34	BCLAF1	chr5:75885718-75886254	GM12878	blood:	n/a	chr5:75886011-75886020
35	BCLAF1	chr5:75852559-75853097	GM12878	blood:	n/a	n/a
36	BCLAF1	chr5:75877985-75878556	GM12878	blood:	n/a	n/a
37	BHLHE40	chr5:75885807-75886280	GM12878	blood:	n/a	n/a
38	BHLHE40	chr5:75904800-75905088	K562	blood:	n/a	n/a
39	BHLHE40	chr5:75897312-75897624	K562	blood:	n/a	n/a
40	BHLHE40	chr5:75840305-75840403	K562	blood:	n/a	n/a
41	BHLHE40	chr5:75839001-75839405	GM12878	blood:	n/a	n/a
42	BHLHE40	chr5:75878083-75878443	K562	blood:	n/a	n/a
43	BHLHE40	chr5:75877874-75878590	GM12878	blood:	n/a	n/a
44	BHLHE40	chr5:75842244-75843807	GM12878	blood:	n/a	n/a
45	BHLHE40	chr5:75839322-75839547	K562	blood:	n/a	n/a
46	BHLHE40	chr5:75879352-75879536	GM12878	blood:	n/a	n/a
47	BRCA1	chr5:75886137-75886143	HepG2	liver:	n/a	n/a
48	BRCA1	chr5:75842646-75842841	GM12878	blood:	n/a	n/a
49	CCNT2	chr5:75879032-75879277	K562	blood:	n/a	n/a
50	CCNT2	chr5:75838441-75839406	K562	blood:	n/a	chr5:75838896-75838916

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:75903700-75903750	ProgFib	skin:	n/a
2	chr5:75903700-75903750	HCPEpiC	choroid plexus:	n/a
3	chr5:75878300-75878350	HRPEpiC	eye:	n/a
4	chr5:75878300-75878350	PANC-1	pancreas:	n/a
5	chr5:75903397-75903447	A549	lung:	n/a
6	chr5:75912664-75912714	U87	brain:	n/a
7	chr5:75912664-75912714	NT2-D1	testis:	n/a
8	chr5:75912664-75912714	SK-N-SH_RA	brain:	n/a
9	chr5:75903700-75903750	MCF-7	breast:	n/a
10	chr5:75878300-75878350	MCF-7	breast:	n/a
11	chr5:75878300-75878350	GM12892	blood:	n/a
12	chr5:75903700-75903750	PFSK-1	brain:	n/a
13	chr5:75903397-75903447	LNCaP	prostate:	n/a
14	chr5:75878300-75878350	SKMC	muscle:	n/a
15	chr5:75903397-75903447	HCF	heart:	n/a
16	chr5:75903700-75903750	SKMC	muscle:	n/a
17	chr5:75903397-75903447	Jurkat	blood:	n/a
18	chr5:75903397-75903447	AG09319	gingival:	n/a
19	chr5:75903700-75903750	HCM	heart:	n/a
20	chr5:75878300-75878350	HCPEpiC	choroid plexus:	n/a
21	chr5:75903700-75903750	RPTEC	kidney:	n/a
22	chr5:75903397-75903447	PFSK-1	brain:	n/a
23	chr5:75878300-75878350	NHDF-neo	bronchial:	n/a
24	chr5:75878300-75878350	ECC-1	luminal epithelium:	n/a
25	chr5:75912664-75912714	SKMC	muscle:	n/a
26	chr5:75903397-75903447	Caco-2	colon:	n/a
27	chr5:75878300-75878350	K562	blood:	n/a
28	chr5:75903700-75903750	HIPEpiC	eye:	n/a
29	chr5:75878300-75878350	BJ	skin:	n/a
30	chr5:75878300-75878350	PrEC	prostate:	n/a
31	chr5:75878300-75878350	ProgFib	skin:	n/a
32	chr5:75878300-75878350	Caco-2	colon:	n/a
33	chr5:75912664-75912714	RPTEC	kidney:	n/a
34	chr5:75878300-75878350	HPAEpiC	pulmonary alveolar:	n/a
35	chr5:75903700-75903750	K562	blood:	n/a
36	chr5:75878300-75878350	AG09319	gingival:	n/a
37	chr5:75903397-75903447	PrEC	prostate:	n/a
38	chr5:75903397-75903447	HL-60	blood:	n/a
39	chr5:75903700-75903750	AG04450	lung:	fetal
40	chr5:75912664-75912714	HNPCEpiC	eye:	n/a
41	chr5:75912664-75912714	H1-hESC	embryonic stem cell:	embryo
42	chr5:75912664-75912714	NHBE	bronchial:	n/a
43	chr5:75912664-75912714	PFSK-1	brain:	n/a
44	chr5:75903700-75903750	PrEC	prostate:	n/a
45	chr5:75878300-75878350	AG04449	skin:	fetal
46	chr5:75903397-75903447	HIPEpiC	eye:	n/a
47	chr5:75912664-75912714	HIPEpiC	eye:	n/a
48	chr5:75903700-75903750	GM12892	blood:	n/a
49	chr5:75903397-75903447	PANC-1	pancreas:	n/a
50	chr5:75903700-75903750	HUVEC	blood vessel:	n/a

(count:43 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:75858031..75860083-chr5:75863526..75866442,2	K562	blood:
2	chr5:75628819..75631136-chr5:75840007..75842103,2	K562	blood:
3	chr5:75826263..75829016-chr5:75865983..75867633,2	K562	blood:
4	chr5:75897438..75897959-chr5:76070126..76070803,2	MCF-7	breast:
5	chr5:75896478..75897915-chr5:75936605..75938172,9	MCF-7	breast:
6	chr5:75897247..75898569-chr5:75937033..75938017,10	MCF-7	breast:
7	chr5:75901625..75904371-chr5:75985828..75988323,2	MCF-7	breast:
8	chr5:75896964..75897974-chr5:75936696..75938042,13	K562	blood:
9	chr5:75858031..75860083-chr5:75863526..75866442,2	K562	blood:
10	chr5:75633417..75634381-chr5:75839891..75840630,3	MCF-7	breast:
11	chr5:75899087..75901579-chr5:75954997..75956885,2	K562	blood:
12	chr5:75896999..75898252-chr5:76070091..76071474,10	K562	blood:
13	chr5:75878372..75880301-chr5:75883948..75885454,2	K562	blood:
14	chr5:75849302..75851121-chr5:75858658..75860638,2	K562	blood:
15	chr5:75861596..75864384-chr5:75866146..75868439,3	K562	blood:
16	chr5:75633462..75634419-chr5:75839412..75840924,7	MCF-7	breast:
17	chr5:75854326..75856350-chr5:75859586..75862495,2	K562	blood:
18	chr5:75699529..75700200-chr5:75878922..75879530,2	K562	blood:
19	chr5:75873843..75876744-chr5:75876856..75878367,2	K562	blood:
20	chr5:75854326..75856350-chr5:75859586..75862495,2	K562	blood:
21	chr5:75878372..75880301-chr5:75883948..75885454,2	K562	blood:
22	chr5:75906449..75908343-chr5:75910406..75912617,2	K562	blood:
23	chr5:75633886..75634436-chr5:75839825..75840735,2	K562	blood:
24	chr5:75698517..75699563-chr5:75839811..75840781,6	MCF-7	breast:
25	chr5:75698659..75699503-chr5:75839829..75840376,2	K562	blood:
26	chr5:75906449..75908343-chr5:75910406..75912617,2	K562	blood:
27	chr5:75896963..75898061-chr5:76070096..76071180,9	MCF-7	breast:
28	chr5:75699826..75701586-chr5:75896000..75897576,2	K562	blood:
29	chr5:75633485..75634409-chr5:75878986..75879511,2	K562	blood:
30	chr5:75897144..75897771-chr5:103707251..103707772,2	MCF-7	breast:
31	chr5:75898209..75899288-chr5:76070136..76071088,4	MCF-7	breast:
32	chr5:75899104..75902387-chr5:75903056..75906871,6	K562	blood:
33	chr5:75897979..75898810-chr5:75937080..75938018,3	K562	blood:
34	chr5:75897329..75897974-chr5:132288926..132289426,2	MCF-7	breast:
35	chr5:75849302..75851121-chr5:75858658..75860638,2	K562	blood:
36	chr5:75906209..75908634-chr5:75909482..75912617,3	K562	blood:
37	chr5:75897975..75898494-chr5:75937296..75938025,2	MCF-7	breast:
38	chr5:75861596..75864384-chr5:75866146..75868439,3	K562	blood:
39	chr5:75910340..75912765-chr5:75915221..75917269,3	K562	blood:
40	chr5:75873843..75876744-chr5:75876856..75878367,2	K562	blood:
41	chr5:75199631..75200148-chr5:75897260..75897978,2	K562	blood:
42	chr5:75906209..75908634-chr5:75909482..75912617,3	K562	blood:
43	chr5:75897714..75898323-chr5:75934762..75935296,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-F2RL2-1	chr5:75904685-75904795	ENSG00000249713.1
2	lnc-F2RL2-1	chr5:75902433-75903909	ENSG00000249713.1

No data

Variant related genes	Relation type
IQGAP2	TF binding region
ENSG00000249713	TF binding region
IQGAP2	CpG island
ENSG00000249713	CpG island
ENSG00000145703	chromatin interactions
ENSG00000249713	chromatin interactions

Extended variants
information (count: 2963 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:2963 , 50 per page) page: 1 2 3 4 5 6 7 ... 60

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9293688	chr5:75839165-75839166	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs186059251	chr5:75839191-75839192	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs565910588	chr5:75839192-75839193	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs565365585	chr5:75839205-75839206	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs531214138	chr5:75839236-75839237	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs551310040	chr5:75839258-75839259	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs114054962	chr5:75839259-75839260	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs190829021	chr5:75839273-75839274	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs183303186	chr5:75839302-75839303	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs566948985	chr5:75839311-75839312	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs112788895	chr5:75839319-75839320	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs147894503	chr5:75839331-75839332	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs386689217	chr5:75839350-75839351	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs10064543	chr5:75839369-75839370	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs189203052	chr5:75839370-75839371	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs536913887	chr5:75839384-75839385	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs550249510	chr5:75839386-75839387	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs556860204	chr5:75839403-75839404	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs570229746	chr5:75839430-75839431	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs573253804	chr5:75839452-75839453	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs550027336	chr5:75839456-75839457	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs114494845	chr5:75839476-75839477	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs552739565	chr5:75839506-75839507	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs113965829	chr5:75839585-75839586	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs111878060	chr5:75839632-75839633	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs112952313	chr5:75839662-75839663	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs7736499	chr5:75839672-75839673	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs544871075	chr5:75839757-75839758	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs141647144	chr5:75839787-75839788	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs563480428	chr5:75839791-75839792	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs192020155	chr5:75839808-75839809	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs78351155	chr5:75839812-75839813	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs548252710	chr5:75839850-75839851	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs182729603	chr5:75839908-75839909	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs376587190	chr5:75839930-75839931	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs144520444	chr5:75839972-75839973	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs552408091	chr5:75839988-75839989	Weak transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs187611685	chr5:75840019-75840020	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs16873476	chr5:75840039-75840040	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs113119569	chr5:75840111-75840112	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs191632640	chr5:75840126-75840127	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs111819737	chr5:75840127-75840128	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs536183405	chr5:75840217-75840218	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs111332411	chr5:75840224-75840225	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs12513951	chr5:75840225-75840226	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs545058463	chr5:75840233-75840234	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs558371447	chr5:75840268-75840269	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs77288787	chr5:75840284-75840285	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs150979362	chr5:75840298-75840299	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs76612467	chr5:75840299-75840300	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Prostate cancer	21965145	CNVD
Spinal muscular atrophy	21762474	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Spinal muscular atrophy	15981080	CNVD
Spinal muscular atrophy	18839960	CNVD
Spinal muscular atrophy	19716110	CNVD
Glioblastoma multiforme	22286061	CNVD
craniofacial dysmorphism	21918468	CNVD
Multiple myeloma	16616336	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	17133270	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Schizophrenia	23813976	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:1484 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:75806800-75839200	Weak transcription	Sigmoid Colon	Sigmoid Colon
2	chr5:75826800-75840000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
3	chr5:75830000-75841600	Enhancers	Stomach Mucosa	stomach
4	chr5:75832200-75840000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr5:75833600-75839800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
6	chr5:75834000-75839200	Enhancers	Primary T helper cells fromperipheralblood	blood
7	chr5:75834200-75839200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr5:75834400-75839200	Weak transcription	Fetal Intestine Small	intestine
9	chr5:75835600-75839800	Weak transcription	Spleen	Spleen
10	chr5:75835600-75871200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr5:75836600-75839200	Weak transcription	Pancreas	Pancrea
12	chr5:75836600-75839600	Weak transcription	HepG2	liver
13	chr5:75837400-75840600	Enhancers	Primary monocytes fromperipheralblood	blood
14	chr5:75837400-75842800	Enhancers	Liver	Liver
15	chr5:75837800-75840600	Enhancers	Fetal Lung	lung
16	chr5:75837800-75841200	Enhancers	Placenta	Placenta
17	chr5:75838000-75840400	Enhancers	Fetal Thymus	thymus
18	chr5:75838000-75840600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr5:75838200-75840200	Enhancers	Small Intestine	intestine
20	chr5:75838200-75840600	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
21	chr5:75838200-75841400	Enhancers	Primary neutrophils fromperipheralblood	blood
22	chr5:75838400-75839200	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
23	chr5:75838400-75839400	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
24	chr5:75838400-75840200	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
25	chr5:75838400-75840200	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
26	chr5:75838400-75840600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
27	chr5:75838400-75840600	Enhancers	Fetal Kidney	kidney
28	chr5:75838600-75839400	Flanking Active TSS	Duodenum Mucosa	Duodenum
29	chr5:75838600-75839400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
30	chr5:75838600-75839600	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
31	chr5:75838600-75839600	Enhancers	Fetal Stomach	stomach
32	chr5:75838600-75840000	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
33	chr5:75838600-75840200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
34	chr5:75838600-75840400	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr5:75838600-75840400	Enhancers	iPS-20b Cell Line	embryonic stem cell
36	chr5:75838600-75840600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
37	chr5:75838800-75839200	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
38	chr5:75838800-75839400	Flanking Active TSS	Primary B cells from cord blood	blood
39	chr5:75838800-75839400	Flanking Active TSS	Primary T cells from cord blood	blood
40	chr5:75838800-75839400	Active TSS	Adipose Nuclei	Adipose
41	chr5:75838800-75839400	Enhancers	Thymus	Thymus
42	chr5:75838800-75839400	Flanking Active TSS	K562	blood
43	chr5:75838800-75839600	Enhancers	ES-I3 Cell Line	embryonic stem cell
44	chr5:75838800-75839600	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
45	chr5:75838800-75839600	Weak transcription	Duodenum Smooth Muscle	Duodenum
46	chr5:75838800-75839800	Flanking Active TSS	GM12878-XiMat	blood
47	chr5:75838800-75840200	Flanking Active TSS	Primary T cells fromperipheralblood	blood
48	chr5:75838800-75840200	Enhancers	Gastric	stomach
49	chr5:75839000-75839200	Flanking Active TSS	Primary hematopoietic stem cells	blood
50	chr5:75839000-75839400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links